1-Benzyl-4-hydroxypiperidineCAS# 4727-72-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 4727-72-4 | SDF | Download SDF |
PubChem ID | 78461 | Appearance | Powder |
Formula | C12H17NO | M.Wt | 191.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1-benzylpiperidin-4-ol | ||
SMILES | C1CN(CCC1O)CC2=CC=CC=C2 | ||
Standard InChIKey | BPPZXJZYCOETDA-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C12H17NO/c14-12-6-8-13(9-7-12)10-11-4-2-1-3-5-11/h1-5,12,14H,6-10H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
1-Benzyl-4-hydroxypiperidine Dilution Calculator
1-Benzyl-4-hydroxypiperidine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.2274 mL | 26.137 mL | 52.2739 mL | 104.5478 mL | 130.6848 mL |
5 mM | 1.0455 mL | 5.2274 mL | 10.4548 mL | 20.9096 mL | 26.137 mL |
10 mM | 0.5227 mL | 2.6137 mL | 5.2274 mL | 10.4548 mL | 13.0685 mL |
50 mM | 0.1045 mL | 0.5227 mL | 1.0455 mL | 2.091 mL | 2.6137 mL |
100 mM | 0.0523 mL | 0.2614 mL | 0.5227 mL | 1.0455 mL | 1.3068 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Kartogenin
Catalog No.:BCC6211
CAS No.:4727-31-5
- H-Ser(Bzl)-OH
Catalog No.:BCC3031
CAS No.:4726-96-9
- Astaxanthin
Catalog No.:BCN2248
CAS No.:472-61-7
- Masticadienolic acid
Catalog No.:BCN5525
CAS No.:472-30-0
- Butyrospermol
Catalog No.:BCN3340
CAS No.:472-28-6
- Telocinobufagin
Catalog No.:BCN2359
CAS No.:472-26-4
- Betulinic acid
Catalog No.:BCN5524
CAS No.:472-15-1
- Ruscogenin
Catalog No.:BCN6287
CAS No.:472-11-7
- MK-0752
Catalog No.:BCC2090
CAS No.:471905-41-6
- Boc-D-Ser(Bzl)-OH
Catalog No.:BCC3448
CAS No.:47173-80-8
- (E)-Aldosecologanin
Catalog No.:BCN4631
CAS No.:471271-55-3
- Bufotaline
Catalog No.:BCN5368
CAS No.:471-95-4
- 8(14),15-Isopimaradien-3-ol
Catalog No.:BCN5526
CAS No.:4728-30-7
- SB 366791
Catalog No.:BCC7128
CAS No.:472981-92-3
- alpha-Cyperone
Catalog No.:BCN1193
CAS No.:473-08-5
- beta-Eudesmol
Catalog No.:BCN6294
CAS No.:473-15-4
- Tolbutamide Sodium
Catalog No.:BCC5632
CAS No.:473-41-6
- Betulin
Catalog No.:BCN5528
CAS No.:473-98-3
- Spegatrine
Catalog No.:BCN4068
CAS No.:47326-53-4
- Carpinontriol B
Catalog No.:BCN8113
CAS No.:473451-73-9
- Boc-Trp(For)-OH
Catalog No.:BCC3456
CAS No.:47355-10-2
- AMG 487
Catalog No.:BCC5140
CAS No.:473719-41-4
- SCH 527123
Catalog No.:BCC1932
CAS No.:473727-83-2
- SCH 563705
Catalog No.:BCC1933
CAS No.:473728-58-4
New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.[Pubmed:19009544]
Arch Pharm (Weinheim). 2008 Dec;341(12):762-73.
A series of 1-benzyl-4-(3-aminopropyloxy)piperidine and 1-benzyl-4-(5-aminopentyloxy)piperidine derivatives has been prepared. The 1-Benzyl-4-hydroxypiperidine derivatives obtained were evaluated for their affinities at recombinant human histamine H(3 )receptor, stably expressed in HEK 293T cells. All compounds investigated show moderate to pronounced in-vitro affinities. The most potent antagonists in this series 9b2 (hH(3)R, pK(i) = 7.09), 9b1 (hH(3)R, pK(i) = 6.78), 9b5 (hH(3)R, pK(i) = 6.99), and 9b6 (hH(3)R, pK(i )= 6.97) were also tested in vitro as H(3 )receptor antagonists - the electrically evoked contraction of the guinea-pig jejunum. The histaminergic H(1) antagonism of selected compounds 9b1, 9b2, and 9b4-9b6 was established on the isolated guinea-pig ileum by conventional methods; the pA(2) values were compared with the potency of pyrilamine. The compounds did not show any H(1) antagonistic activity (pA(2) < 4; for pyrilamine pA(2) = 9.53).